D-threo-2-Pentulose,5-deoxy-1-C-[(2S,3S)-7-[[2,6-dideoxy-3-O-(2,6-dideoxy-b-D-arabino-hexopyranosyl)-b-D-arabino-hexopyranosyl]oxy]-3-[(O-2,6-dideoxy-3-C-methyl-b-D-ribo-hexopyranosyl-(1®3)-O-2,6-dideoxy-b-D-lyxo-hexopyranosyl-(1®3)-2,6-dideoxy-b-D-arabino-hexopyranosyl)oxy]-1,2,3,4-tetrahydro-5,10-dihydroxy-6-methyl-4-oxo-2-anthracenyl]-1-O-methyl-,(1S)- (9CI) cas no:18378-89-7
Synonyms: Mithramycin(8CI);A 2371;Antibiotic LA 7017;Aureolic acid;Mithracin;Mithramycin A;Mitramycin;NSC 24559;PA 144;Plicamycin;Plicatomycin;[1S(2S,3S)]-5-Deoxy-1-C-[7-[[2,6-dideoxy-3-O-(2,6-dideoxy-b-D-arabino-hexopyranosyl)-b-D-arabino-hexopyranosyl]oxy]-3-[(O-2,6-dideoxy-3-C-methyl-b-D-ribo-hexopyranosyl-(1?;3)-O-2,6-dideoxy-b-D-arabino-hexopyranosyl-(1?;3)-2,6-dideoxy-b-D-lyxo-hexopyranosyl)oxy]-1,2,3,4-tetrahydro-5,10-dihydroxy-6-methyl-4-oxo-2-anthracenyl]-1-O-methyl-D-threo-2-pentulose;
NameD-threo-2-Pentulose,5-deoxy-1-C-[(2S,3S)-7-[[2,6-dideoxy-3-O-(2,6-dideoxy-b-D-arabino-hexopyranosyl)-b-D-arabino-hexopyranosyl]oxy]-3-[(O-2,6-dideoxy-3-C-methyl-b-D-ribo-hexopyranosyl-(1®3)-O-2,6-dideoxy-b-D-lyxo-hexopyranosyl-(1®3)-2,6-dideoxy-b-D-arabino-hexopyranosyl)oxy]-1,2,3,4-tetrahydro-5,10-dihydroxy-6-methyl-4-oxo-2-anthracenyl]-1-O-methyl-,(1S)- (9CI)
CAS18378-89-7
SynonymsMithramycin(8CI);A 2371;Antibiotic LA 7017;Aureolic acid;Mithracin;Mithramycin A;Mitramycin;NSC 24559;PA 144;Plicamycin;Plicatomycin;[1S(2S,3S)]-5-Deoxy-1-C-[7-[[2,6-dideoxy-3-O-(2,6-dideoxy-b-D-arabino-hexopyranosyl)-b-D-arabino-hexopyranosyl]oxy]-3-[(O-2,6-dideoxy-3-C-methyl-b-D-ribo-hexopyranosyl-(1?;3)-O-2,6-dideoxy-b-D-arabino-hexopyranosyl-(1?;3)-2,6-dideoxy-b-D-lyxo-hexopyranosyl)oxy]-1,2,3,4-tetrahydro-5,10-dihydroxy-6-methyl-4-oxo-2-anthracenyl]-1-O-methyl-D-threo-2-pentulose;
EINECS(EC#)232-455-8
Molecular FormulaC52H76 O24
Molecular Weight1085.14544
Appearanceyellow powder
refractive index1.639
storage temp2-8°C
Globally Harmonized System of Classification adn Labelling of Chemicals(GHS)
Hazardclass6.1(b)
Hazard Xn: Harmful;
Risk R22
Safety
A deadly poison by intravenous, intraperitoneal, and subcutaneous routes. Moderately toxic by ingestion. Human systemic effects by ingestion: blood thrombocytopenia. An experimental teratogen. Experimental reproductive effects. Human mutation data reported. When heated to decomposition it emits acrid smoke and irritating fumes.
Hazard Codes:
Xn: Harmful
T+: Very toxic
Risk Statements:
R22: Harmful if swallowed.
R26/27/28: Very toxic by inhalation, in contact with skin and if swallowed.
Safety Statements:
S45: In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.)
S38: In case of insufficient ventilation, wear suitable respiratory equipment.
S36/37/39: Wear suitable protective clothing, gloves and eye/face protection.
S28: After contact with skin, wash immediately with plenty of soap-suds.
S22: Do not breathe dust.
RIDADR:3249
WGK Germany: 3
RTECS: PZ2800000
F: 10 Keep under argon.
HazardClass: 6.1(b)
PackingGroup: III
| 1. |
|
dnd-hmn:hla 1 mg/L
|
|
CNREA8 Cancer Research. 45 (1985),2813. |
| 2. |
|
msc-hmn:hla 40 µg/L
|
|
CNREA8 Cancer Research. 45 (1985),2813. |
| 3. |
|
orl-hmn TDLo:50 µg/kg/5D:BLD
|
|
CORTBR Clinical Orthopaedics and Related Research. 127 (1977),106. |
| 4. |
|
ipr-rat LD50:2500 µg/kg
|
|
ADTEAS Advances in Teratology. 3 (1968),181. |
| 5. |
|
ivn-rat LD50:1741 µg/kg
|
|
NCICP* Progress Report Submitted to the National Cancer Institute by Charles Pfizer and Company |
| 6. |
|
orl-mus LD50:500 mg/kg
|
|
85GDA2 CRC Handbook of Antibiotic Compounds, Volumes 1-9. 1 (1980),342. |
| 7. |
|
ipr-mus LD50:1090 µg/kg
|
|
ANTBAL Antibiotiki. 21 (1976),258. |
| 8. |
|
scu-mus LD50:2810 µg/kg
|
|
ANTBAL Antibiotiki. 21 (1976),258. |
| 9. |
|
ivn-mus LD50:350 µg/kg
|
|
85ERAY Antibiotics: Origin, Nature, and Properties. 2 (1978),1405. |
| 10. |
|
ivn-dog LD50:250 µg/kg
|
|
85ERAY Antibiotics: Origin, Nature, and Properties. 2 (1978),1405. |
| 11. |
